Process for reducing reflex tachycardia in the treatment of hype

Details Process for reducing reflex tachycardia in the treatment of hype Process for reducing reflex tachycardia in the treatment of hype

1987-01-21

1988-05-24

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514401, A61K 31415, A61K 31495

Patent

active

047466600

ABSTRACT:
The invention relates to a new process for the treatment of hypertension and thromboembolic diseases in humans by simultaneous administration of (.+-.)- or (-)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene hydrochloride on the one side, and 4,5-dihydro-6-[4-(1-imidazolyl)-phenyl]-5-methyl-3(2H)-pyridazinone or 4,5-dihydro-6-[4-(1-imidazolyl)-thien-2-yl]-5-methyl-3(2H)-pyridazinone, on the other side, as the active substances.

REFERENCES:
patent: 4518783 (1985-05-01), Biedermann et al.
patent: 4643998 (1987-02-01), Hilboll et al.
Derwent Publication 67658x/36 of German Patent 1,795,843, 1 page (1968).

Affiliated with

Also associated with

Rating

Process for reducing reflex tachycardia in the treatment of hype does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for reducing reflex tachycardia in the treatment of hype, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for reducing reflex tachycardia in the treatment of hype will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1058520